Business Daily Media

Business Marketing

.

Eisai, Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate

  • Written by ACN Newswire - Press Releases

Eisai, Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate

Tokyo and New York, Jun 18, 2021 - (JCN Newswire) - Eisai Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the companies have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercialization of MORAb-202, an antibody drug conjugate (ADC).

MORAb-202 is Eisai's first ADC

Read more //?#

Popular

Instinct Education Launch Free Online Business Course For Entrepreneurs

Instinct Education, one of Australia’s leading business education companies, have recently announced the launch of their brand new online business course - Genesis. The free online training program has been designed for coach...

Jake Dyson reveals the next stage of Dyson’s £2.75bn five-year investment plan

Dyson engineers are working on a new generation of intelligent, self-improving, connected products, as the company builds up its software-based team, Jake Dyson, Chief Engineer, reveals in a new Dyson YouTube video. He says th...

3 things I learned from reinventing my business when we nearly had to close

Lockdowns were hard for so many people. As a business owner with a physical store that ended up being deemed as “non essential”, myself and my family ended up struggling alongside so many others. In fact, the company that my...